Enhanced clonogenic survival induced by protein tyrosine phosphatase (PTP) inhibition after Cr(VI) exposure is mediated by c-Raf and Ras activity

被引:7
作者
Bae, Dongsoon [1 ]
Camilli, Tura C. [1 ]
Ha, Ngoc-Tram [1 ]
Ceryak, Susan [1 ,2 ,3 ]
机构
[1] George Washington Univ, Med Ctr, Dept Physiol & Pharmacol, Washington, DC 20037 USA
[2] George Washington Univ, Med Ctr, Dept Med, Washington, DC 20037 USA
[3] George Washington Univ, Med Ctr, GW Canc Inst, Washington, DC 20037 USA
基金
美国国家卫生研究院;
关键词
PTP inhibitor; Sodium orthovanadate; Hexavalent chromium [Cr(VI); Genotoxic stress; Clonogenic lethality; Cell survival; Ras/Raf/Mek/Erk pathway; SIGNAL-REGULATED KINASE; EPITHELIAL-CELL PROLIFERATION; SODIUM ORTHOVANADATE; PHOSPHATIDYLINOSITOL; 3-KINASE/AKT; CEREBRAL-ISCHEMIA; CYCLE PROGRESSION; HUMAN FIBROBLAST; ADAPTER PROTEIN; FAMILY KINASES; ACTIVATION;
D O I
10.1016/j.cellsig.2009.01.011
中图分类号
Q2 [细胞生物学];
学科分类号
071013 [干细胞生物学];
摘要
Our recent studies showed that maintenance of protein tyrosine phosphorylation by PTP inhibition enhanced cell growth, clonogenic survival, and mutagenesis after a single low-level Cr(VI) exposure, thereby suggesting that tyrosine phosphorylation-dependent signaling may govern inappropriate survival in human lung fibroblasts (HLFs). Our goal is to identify specific phospho-tyrosine regulator(s)/downstream effectors involved in enhanced survival after Cr(VI) exposure and PTP inhibition. Phosphotyrosine profiling array showed that PTP inhibition following Cr(VI) exposure increased tyrosine phosphorylation of specific proteins, such as FGR and ABL, which are upstream regulators of both Erk and Akt pathways. To explore the roles of these pathways in the PTP-induced increase in clonogenic survival after Cr(VI) exposure, we examined the effect of combined Akt1 and Erk1/2 knockdown via siRNA technology. Akt1 and/or Erk1/2 silencing had no effect on the PTP inhibitor-induced increase in survival following Cr(VI) exposure, suggesting the presence of non-Akt/non-Erk-mediated survival signaling. Interestingly, geldanamycin, an HSP90 inhibitor and nonspecific Raf inhibitor, abrogated the PTP inhibitor-mediated increase in survival following Cr(VI) exposure and abolished the expression/activity of c-Raf and activity of Mek. These findings prompted us to explore upstream regulators of Erk, i.e., Ras, c-Raf and Mek for their potential roles in clonogenic survival. GW5074, a specific c-Raf kinase inhibitor did not alter the effect of the PTP inhibitor but decreased Cr(VI)-mediated clonogenic lethality, potentially though Mek hyperactivation. A genetic approach with a c/a Mek1 mutant also showed that Mek activity was not directly associated with the PTP inhibitor effect. Finally, a genetic approach with din or c/a Ras and c-Raf mutants, showed that Ras and c-Raf activities play a substantive role in enhancing clonogenic survival by PTP inhibition following Cr(VI) insult. In conclusion. these studies highlight a novel pro-survival mechanism for clonogenic survival in the face of genotoxic stress in the presence of PTP inhibition via an Erk/Mek-independent and Ras/c-Raf-dependent regulation in normal human lung fibroblasts. Published by Elsevier Inc.
引用
收藏
页码:727 / 736
页数:10
相关论文
共 48 条
[1]
Bypass of hexavalent chromium-induced growth arrest by a protein tyrosine phosphatase inhibitor: Enhanced survival and mutagenesis [J].
Bae, Dongsoon ;
Camilli, Tura C. ;
Chun, Gina ;
Lal, Madhu ;
Wright, Kristen ;
O'Brien, Travis J. ;
Patierno, Steven R. ;
Ceryak, Susan .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2009, 660 (1-2) :40-46
[2]
Direct evidence from siRNA-directed "knock down" that p16INK4a is required for human fibroblast senescence and for limiting ras-induced epithelial cell proliferation [J].
Bond, J ;
Jones, C ;
Haughton, M ;
DeMicco, C ;
Kipling, D ;
Wynford-Thomas, D .
EXPERIMENTAL CELL RESEARCH, 2004, 292 (01) :151-156
[3]
All in the family? New insights and questions regarding interconnectivity of Ras, Rap1 and Ral [J].
Bos, JL .
EMBO JOURNAL, 1998, 17 (23) :6776-6782
[4]
Induction of pro-apoptotic and cell cycle-inhibiting genes in chromium (VI)-treated human lung fibroblasts: Lack of effect of ERK [J].
Ceryak, S ;
Zingariello, C ;
O'Brien, T ;
Patierno, SR .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 2004, 255 (1-2) :139-149
[5]
Chang FM, 2003, INT J ONCOL, V22, P469
[6]
The c-Raf inhibitor GW5074 provides neuroprotection in vitro and in an animal model of neurodegeneration through a MEK-ERK and Akt-independent mechanism [J].
Chin, PC ;
Liu, L ;
Morrison, BE ;
Siddiq, A ;
Ratan, RR ;
Bottiglieri, T ;
D'Mello, SR .
JOURNAL OF NEUROCHEMISTRY, 2004, 90 (03) :595-608
[7]
Involvement of the ERK signaling cascade in protein kinase C-mediated cell cycle arrest in intestinal epithelial cells [J].
Clark, JA ;
Black, AR ;
Leontieva, OV ;
Frey, MR ;
Pysz, MA ;
Kunneva, L ;
Woloszynska-Read, A ;
Roy, D ;
Black, JD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (10) :9233-9247
[8]
PI3K-FRAP/mTOR pathway is critical for hepatocyte proliferation whereas MEK/ERK supports both proliferation and survival [J].
Coutant, A ;
Rescan, C ;
Gilot, D ;
Loyer, P ;
Guguen-Guillouzo, C ;
Baffet, G .
HEPATOLOGY, 2002, 36 (05) :1079-1088
[9]
A SYNTHETIC INHIBITOR OF THE MITOGEN-ACTIVATED PROTEIN-KINASE CASCADE [J].
DUDLEY, DT ;
PANG, L ;
DECKER, SJ ;
BRIDGES, AJ ;
SALTIEL, AR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (17) :7686-7689
[10]
Novel targets for lung cancer therapy: Part II [J].
Dy, GK ;
Adjei, AA .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (13) :3016-3028